Tags

Type your tag names separated by a space and hit enter

I.v. infusion of opioids for cancer pain: clinical review and guidelines for use.
Cancer Treat Rep. 1986 May; 70(5):575-81.CT

Abstract

To assess the safety, efficacy, and use of continuous iv infusion (CI) of opioids for cancer pain, we reviewed the clinical experience of 36 patients who received 46 CIs. CI was always preceded by a period of repetitive dosing of opioids. Morphine was used in 36 CIs, methadone in four, hydromorphone in four, oxymorphone in one, and levorphanol in one. Mean doses during CI were the morphine equivalent of 17 mg/hour (range, 0.7-100) at the start, 69 mg/hour (range, 4-480) at the maximum, and 52 mg/hour (range, 1-480) at termination. Pain relief was acceptable during 28 CIs, unacceptable during 17, and unknown during one. There were few toxic effects other than sedation. Twenty-five patients died, 12 resumed im or oral opioids, six continued CI with a different opioid (yielding analgesia in two), and outcome was undetermined in three. This review suggests that (a) CI is safe, (b) analgesia may require rapid escalation of infusion rates, (c) patient response varies and lack of acceptable analgesia may occur in up to one-third, (d) ineffective CI with one drug may be followed by success with another, (e) CI should be preceded by a period of repetitive iv boluses with the same drug, and (f) guidelines can be developed which incorporate pharmacokinetic principles.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

2423236

Citation

Portenoy, R K., et al. "I.v. Infusion of Opioids for Cancer Pain: Clinical Review and Guidelines for Use." Cancer Treatment Reports, vol. 70, no. 5, 1986, pp. 575-81.
Portenoy RK, Moulin DE, Rogers A, et al. I.v. infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treat Rep. 1986;70(5):575-81.
Portenoy, R. K., Moulin, D. E., Rogers, A., Inturrisi, C. E., & Foley, K. M. (1986). I.v. infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treatment Reports, 70(5), 575-81.
Portenoy RK, et al. I.v. Infusion of Opioids for Cancer Pain: Clinical Review and Guidelines for Use. Cancer Treat Rep. 1986;70(5):575-81. PubMed PMID: 2423236.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - I.v. infusion of opioids for cancer pain: clinical review and guidelines for use. AU - Portenoy,R K, AU - Moulin,D E, AU - Rogers,A, AU - Inturrisi,C E, AU - Foley,K M, PY - 1986/5/1/pubmed PY - 1986/5/1/medline PY - 1986/5/1/entrez SP - 575 EP - 81 JF - Cancer treatment reports JO - Cancer Treat Rep VL - 70 IS - 5 N2 - To assess the safety, efficacy, and use of continuous iv infusion (CI) of opioids for cancer pain, we reviewed the clinical experience of 36 patients who received 46 CIs. CI was always preceded by a period of repetitive dosing of opioids. Morphine was used in 36 CIs, methadone in four, hydromorphone in four, oxymorphone in one, and levorphanol in one. Mean doses during CI were the morphine equivalent of 17 mg/hour (range, 0.7-100) at the start, 69 mg/hour (range, 4-480) at the maximum, and 52 mg/hour (range, 1-480) at termination. Pain relief was acceptable during 28 CIs, unacceptable during 17, and unknown during one. There were few toxic effects other than sedation. Twenty-five patients died, 12 resumed im or oral opioids, six continued CI with a different opioid (yielding analgesia in two), and outcome was undetermined in three. This review suggests that (a) CI is safe, (b) analgesia may require rapid escalation of infusion rates, (c) patient response varies and lack of acceptable analgesia may occur in up to one-third, (d) ineffective CI with one drug may be followed by success with another, (e) CI should be preceded by a period of repetitive iv boluses with the same drug, and (f) guidelines can be developed which incorporate pharmacokinetic principles. SN - 0361-5960 UR - https://www.unboundmedicine.com/medline/citation/2423236/I_v__infusion_of_opioids_for_cancer_pain:_clinical_review_and_guidelines_for_use_ L2 - https://medlineplus.gov/cancerinchildren.html DB - PRIME DP - Unbound Medicine ER -